Zykadia (ceritinib) 150 mg, 150 capsules, Novartis, Switzerland, original Zykadia (ceritinib) is used for certain ALK-positive non-small cell lung cancers. Medicine delivery from Europe with storage conditions maintained. Payment on delivery. Order at +380996042415 via Viber or WhatsApp.
Delivery methods
- We can ship by mail to any European country with a delivery time of 8-10 days. Only medications that do not require refrigeration possible shipping. Shipping costs are 40-50 euro, depending on the destination country.
Delivery time
- Originator medicines: 8-10 days
- Generic medicines: 8-10 days
Payment methods
- Bank transfer to the settlement account after receiving the order
Price on request
Indications
The drug Zykadia®, as monotherapy is indicated as a first-line drug for the treatment of adult patients with ALK (anaplastic lymphoma kinase)-positive diffuse non-small cell lung cancer (NSCLC).
The drug is indicated as monotherapy for the treatment of adult patients suffering from ALK (anaplastic lymphoma kinase)-positive diffuse non-small cell lung cancer (NSCLC) previously treated with crizotinib.
- Trade name:Zykadia
- Chemical name:Ceritinib
- Dosage:150 mg
- Quantity:70
- Dosage form:Capsules
- Manufacturer:Novartis, Switzerland
No reviews yet
